APA (7th ed.) Citation

DK, C., & MA, R. (2026). In severe chronic rhinosinusitis with polyps and asthma, dupilumab improved nasal polyp score and sense of smell vs. omalizumab at 24 wk. Annals of internal medicine, 179(2), JC20. https://doi.org/10.7326/ANNALS-25-05457-JC

Chicago Style (17th ed.) Citation

DK, Chu, and Rank MA. "In Severe Chronic Rhinosinusitis with Polyps and Asthma, Dupilumab Improved Nasal Polyp Score and Sense of Smell Vs. Omalizumab at 24 Wk." Annals of Internal Medicine 179, no. 2 (2026): JC20. https://doi.org/10.7326/ANNALS-25-05457-JC.

MLA (9th ed.) Citation

DK, Chu, and Rank MA. "In Severe Chronic Rhinosinusitis with Polyps and Asthma, Dupilumab Improved Nasal Polyp Score and Sense of Smell Vs. Omalizumab at 24 Wk." Annals of Internal Medicine, vol. 179, no. 2, 2026, p. JC20, https://doi.org/10.7326/ANNALS-25-05457-JC.